| 1. |
|
| 2. |
|
| 3. |
|
| 4. |
|
| 5. |
|
| 6. |
Georgiou K, Marinov B, Farooqi AA, et al. Gut Microbiota in Lung Cancer: Where Do We Stand? Int J Mol Sci, 2021, 22(19): 10429.
|
| 7. |
|
| 8. |
|
| 9. |
|
| 10. |
|
| 11. |
|
| 12. |
Riquelme E, Zhang Y, Zhang L, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell, 2019, 178(4): 795-806. e712.
|
| 13. |
Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell, 2022, 185(8): 1356-1372. e1326.
|
| 14. |
|
| 15. |
|
| 16. |
|
| 17. |
|
| 18. |
|
| 19. |
|
| 20. |
|
| 21. |
Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell, 2022, 185(20): 3789-3806. e3717.
|
| 22. |
|
| 23. |
|
| 24. |
|
| 25. |
Liu NN, Yi CX, Wei LQ, et al. The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell, 2023, 41(11): 1927-1944. e1929.
|
| 26. |
|
| 27. |
|
| 28. |
|
| 29. |
|
| 30. |
|
| 31. |
|
| 32. |
Khan FH, Bhat BA, Sheikh BA, et al. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy. Semin Cancer Biol, 2022, 86(Pt 3): 732-742.
|
| 33. |
|
| 34. |
|
| 35. |
|
| 36. |
|
| 37. |
|
| 38. |
|
| 39. |
|
| 40. |
|
| 41. |
|
| 42. |
|
| 43. |
|
| 44. |
|
| 45. |
|
| 46. |
|
| 47. |
|
| 48. |
Jin C, Lagoudas GK, Zhao C, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell, 2019, 176(5): 998-1013. e1016.
|
| 49. |
|
| 50. |
|
| 51. |
|
| 52. |
Guo S, Chen J, Chen F, et al. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16. Gut, 2020: gutjnl-2020-321187.
|
| 53. |
|
| 54. |
|
| 55. |
|
| 56. |
|
| 57. |
|
| 58. |
|
| 59. |
|
| 60. |
|
| 61. |
|
| 62. |
|
| 63. |
Battaglia TW, Mimpen IL, Traets JJH, et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell, 2024, 187(9): 2324-2335. e2319.
|
| 64. |
|
| 65. |
|
| 66. |
|
| 67. |
|
| 68. |
|